InsidersTradesSigma
Discover the full insider trade history of Citius Pharmaceuticals, Inc., a listed issuer based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Market capitalisation: €16.9m. The latest transaction was disclosed on 30 August 2024 (Levée d'options). Among the most active insiders: Holuka Eugene Myron. All data is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
2 of 2 declarations